Cargando…
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
Colesevelam HCl is a bile acid sequestrant (BAS) which has been specifically designed with a unique structure for the purpose of improving tolerability and reducing potential drug interactions compared to older BAS, such as cholestyramine and colestipol. As a class, BAS are known to reduce cholester...
Autores principales: | Bays, Harold, H Jones, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291317/ https://www.ncbi.nlm.nih.gov/pubmed/18078024 |
Ejemplares similares
-
Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
por: Sekhri, Kavita, et al.
Publicado: (2011) -
Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
por: Bays, Harold E
Publicado: (2012) -
Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action
por: Zema, Michael James
Publicado: (2012) -
Role of Colesevelam in Combination Lipid-Lowering Therapy
por: Jones, Michael R., et al.
Publicado: (2013) -
Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
por: Nwose, Oliseyenum M., et al.
Publicado: (2013)